CPhI North America 2018

Sterling pumps $8m into small to mid-scale API capabilities in UK

By Flora Southey contact

- Last updated on GMT

(Image: Getty/Nordroden)
(Image: Getty/Nordroden)
Sterling Pharma Solutions is boosting its small to mid-scale active pharmaceutical ingredient manufacturing capabilities, marking the CDMO’s second £6m investment in as many years.

The contract development and manufacturing organization’s (CDMO) investment will see reactor trains at scales of 225L, 500L and 1,360L added to its Dudley, UK-based site, which will increase capacity by 33%.

The investment will boost the CDMO’s small to mid-scale batch production capabilities, sales and marketing director Andrew Henderson told us at CPhI North America last week.

“We will are adding three reactor trains at the site,” ​he told us, bringing the total number of trains to eight.

According to the firm, the investment responds to increased demand for active pharmaceutical batch sizes in the 10-100kg range.

“More and more of our customers are interested in outsourcing the entire process and by adding more small-scale equipment to our facility we’ll be able to increase our capacity and cater for additional projects from proof of concept through to commercial manufacture,”​ said CEO Kevin Cook in a statement.

The investment marks the firm’s second £6m ($8m) investment in two years.

In October 2017, we reported​ that Sterling was adding four milling areas to its Dudley, UK-based site to increase its solid form capabilities.

The investment also saw the CDMO add polymorph screening, salt selection, particle engineering and crystallisation scale-up capabilities to its drug development services, as well as occupational exposure band (OEB) 4 classified molecule capabilities and International Standards Organisation (ISO) 9 cleanrooms.

The facilities are expected to be operational by mid-2018.

Related news

Show more

Related products

show more

Eastern & Western Manufacturing Solutions

Eastern & Western Manufacturing Solutions

Piramal Pharma Solutions | 07-Dec-2021 | Technical / White Paper

The best manufacturing site for a product can change throughout the life cycle. When bringing new drugs to market, biopharma companies may benefit from...

Flexibility and capability in pre-filled syringes

Flexibility and capability in pre-filled syringes

Curia | 15-Nov-2021 | Technical / White Paper

Pre-filled syringes have risen in popularity in recent years but the pandemic’s impact on drug development, manufacturing and patient care has created...

LACTIUM®: dairy bioactive to soothe your pet

LACTIUM®: dairy bioactive to soothe your pet

Ingredia | 12-Oct-2021 | Infographic

Lactium® gives you the chance to better meet your pet’s needs for a more harmonious life together. Lactium® acts on the brain and has no side-effects,...

Related suppliers

Follow us


View more